Study of a new device to treat aortic valve leak in LVAD patients
Part of Heart & circulation clinical trials.
This trial tests a new device to fix a leaky aortic valve in people who already have a mechanical heart pump (LVAD). The goal is to help the pump work better and reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a left ventricular assist device (LVAD), a mechanical pump that helps your heart pump blood.
- You must have a significant leak in your aortic valve (the valve connecting your heart to your body) that is causing your LVAD to work harder.
- You should have symptoms like shortness of breath or fatigue with light activity or at rest.
- Your heart team must agree that traditional open-heart surgery is too risky for you.
- Your heart's structure must be suitable for the study device being placed without surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, less invasive device called J-Valve for people with severe aortic regurgitation (a leaky aortic valve). It is placed through a tube in the leg artery, avoiding open-heart surgery, and may help those who are at high risk for surgery.
This trial compares a new catheter-based valve (J-Valve) with open-heart surgery for people with severe aortic regurgitation, a condition where the aortic valve doesn't close tightly. It aims to see which treatment is safer and more effective.
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This study is testing a new, less invasive heart valve system (TaurusTrio) for people with severe aortic regurgitation (a leaky aortic valve) who cannot have open-heart surgery. It aims to see if the valve is safe and works well to improve symptoms.
Hear when a new Aortic Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.